Top tips: ⭐️ Summarise the key facts but always provide the source ⭐️ Learn from mistakes to improve what you have ⭐️ Have high quality source material- scan multiple resources for the best quality info and latest news! @RheumNow #EULAR2026

What makes a good rheum learning platform? @rheumnow’s Dr Jack Cush gives a masterclass in online learning and medical education, including the background to RheumNow. #EULAR2026 @EMEUNET https://t.co/2cXpRXPK13

• https://x.com/DrMiniDey/status/2062847194902720581/photo/1
• https://x.com/DrMiniDey/status/2062847194902720581/photo/1

What do you think about this cartoon-style format for posters? A- I love it! B- It’s Ok but I prefer classic As for the content: Axia digital therapeutic app improves mobility, BASDAI, sleep an sexual function in 32 patients #POS0199 #EULAR2026 @rheumnow https://t.co/mV83dMF4vi

• https://x.com/Nellziade/status/2062847138959081686/photo/1

Our expanded #EULAR2026 coverage is made possible by support from Bristol Myers Squibb and UCB. All content is independently chosen and produced by the RheumNow faculty.

#EULAR2026 OP0341 Phase I Obe-Cel Autologous CD19 CAR-T (advantage: 4-1BB-ζ, fast off-rate binding domain to reduce immunotoxicity) showed efficacy and acceptable safety with either 50M or 100M dose in N=13 patients with refractory #SLE. Need longterm data & comparators @RheumNow https://t.co/qxidRi0jit

• https://x.com/Yuz6Yusof/status/2062846673345233231/photo/1

OMRF study: Anti-Ro neg Sjögren’s patients share similar molecular profiling as anti-Ro positive pts: innate immune signaling, immune cell activation, inflammation, autophagy, apoptosis, and metabolic dysregulation pathways #EULAR2026 @RheumNow https://t.co/zJm6EbpyIB

• https://x.com/KDAO2011/status/2062845784001798348/photo/1

Which imaging test has the highest carbon footprint??? Think wisely before prescribing 🩻 #EULAR2026 @RheumNow https://t.co/36Ej8smWRd

• https://x.com/Nellziade/status/2062844472522666061/photo/1

Did you take part in #RheumaVision this year? @cristianasieiro takes us through the past, present & future of this innovative initiative, which held its final yesterday at #EULAR2026. You can watch all the videos online- and be sure to participate next year! @EMEUNET @RheumNow https://t.co/liWzYYbIxI

• https://x.com/DrMiniDey/status/2062843422172385751/photo/1

🩺🌳When good clinical practice meets reducing environmental burden of healthcare: Rheumatologists can do a lot! Less is more ⬇️ Thank you @eular_org for planning environmental awareness sessions Looking forward to #greener congresses #EULAR2026 @RheumNow https://t.co/5FwARRi92m

• https://x.com/Nellziade/status/2062843363074703703/photo/1

#RheumMadness comes to #EULAR2026! Dr David Leverenz takes us through the background and process of this firm favourite in rheum education. An excellent example of gamification for medical education more broadly. @RheumNow https://t.co/lmgkJbTgBm

• https://x.com/DrMiniDey/status/2062842842406375826/photo/1

Another reason for NOT prescribing ANA (and other tests) as a “screening” test when not indicated: High carbon footprint! #EULAR2026 @rheumnow https://t.co/BAuzQuZ0Iv

• https://x.com/Nellziade/status/2062841554012610987/photo/1

#EULAR2026 OP0340 WK84 data of single arm Phase 2 Daratumumab (CD38 plasma depleter) weekly for 8 doses with background IS in N=10 #SLE: rapid reduction of antidsDNA & efficacy. 6/10 relapsed from WK20; 5/10 had low IgG and needed IVIG. Promising but Not so durable @RheumNow https://t.co/UrTywqkQ4F

• https://x.com/Yuz6Yusof/status/2062840252742471836/photo/1

What does remission look like for people living with PsA? Much more than the absence of swollen joints Absence of pain Skin management Ability to resume daily activities Sustained over time A definition not always reflected in our disease activity scores #POS0294 #EULAR2026 https://t.co/VCnMGAOVYm

• https://x.com/AurelieRheumo/status/2062840184509468983/photo/1
• https://x.com/AurelieRheumo/status/2062840184509468983/photo/1